XML 17 R6.htm IDEA: XBRL DOCUMENT v3.5.0.2
Condensed Consolidated Statements of Cash Flows - USD ($)
 6 Months Ended
Jun. 30, 2016
Jun. 30, 2015
Cash flows from operating activities:    
Net loss $ (937,730) $ (851,599)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 5,723 6,051
Bad debt expense 12,166 4,137
Amortization of deferred financing costs 1,415 7,758
Amortization of beneficial conversion option 0 49,315
Stock issued for services 62,500 0
Stock option compensation 90,351 395,000
Note conversion warrant expense 137,970 0
Changes in operating assets and liabilities:    
Accounts receivable (76,491) (134,043)
Prepaid expenses and other current assets (123,364) (6,200)
Accounts payable and accrued expenses (97,012) 193,830
Other long-term liabilities - related parties (12,852) 57,925
Deferred interest expense 15,940 18,867
Deferred revenues (158,606) (75,065)
Total adjustments (142,260) 517,575
Net cash used in operating activities (1,079,990) (334,024)
Cash flows from investing activities:    
Purchases of property and equipment (3,011) 0
Net cash used in investing activities (3,011) 0
Cash flows from financing activities:    
Sale of Common Stock 559,285 0
Exercise of stock options 3,500 0
Proceeds from notes payable - related parties 0 360,000
Repayment of notes payable (120,000) (96,000)
Repayment of notes payable - related parties (75,060) (15,305)
Net cash provided by financing activities 367,725 248,695
Net increase (decrease) in cash (715,276) (85,329)
Cash - beginning of period 1,117,118 184,081
Cash - end of period 401,842 98,752
Supplemental disclosure of cash flow information:    
Cash paid during the period for interest and taxes 28,475 23,492
Supplemental disclosure of non-cash financing activities:    
Accrued interest notes payable converted to equity 35,038 0
Notes payable conversion warrant expense 113,762 0
Notes payable conversion underwriting warrant expense 24,207 0
Notes payable converted to equity $ 135,000 $ 0